Search research articles
Contact Us
Filters
Showing results (401-410 of 497) with videos related to
Page
of 50
Sort By:
Bratislavske Lekarske Listy
|
November 2, 2010
Protection of ovarian tissue from radiotherapy
C Pafumi, S M Iraci, G Abbate, et al.
JAMA Network Open
|
September 5, 2020
Assessment of Probable Opioid Use Disorder Using Electronic Health Record Documentation
Sarah A Palumbo, Kayleigh M Adamson, Sarathbabu Krishnamurthy, et al.
International Journal of Hematology
|
June 27, 2020
High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity
Giovanni Caocci, Marco Vignetti, Andrea Patriarca, et al.
Cell Proliferation
|
February 16, 2023
Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno-microenvironment in multiple myeloma
Alessandro Barbato, Cesarina Giallongo, Sebastiano Giallongo, et al.
Redox Biology
|
September 1, 2020
Iron regulates myeloma cell/macrophage interaction and drives resistance to bortezomib
Giuseppina Camiolo, Alessandro Barbato, Cesarina Giallongo, et al.
Leukemia & Lymphoma
|
June 23, 2017
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide
Rossana Maffei, Stefania Fiorcari, Silvia Martinelli, et al.
Cancer Medicine
|
September 18, 2015
Early lenalidomide treatment for low and intermediate-1 International Prognostic Scoring System risk myelodysplastic syndromes with del(5q) before transfusion dependence
Esther N Oliva, Michael Lauseker, Maria Antonietta Aloe Spiriti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 2011
Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party
G D'Arena, C G Valentini, G Pietrantuono, et al.
International Journal of Molecular Sciences
|
February 3, 2019
α-Lipoic Acid Reduces Iron-induced Toxicity and Oxidative Stress in a Model of Iron Overload
Giuseppina Camiolo, Daniele Tibullo, Cesarina Giallongo, et al.
Leukemia
|
February 5, 2011
Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement
M A Dimopoulos, A Palumbo, M Attal, et al.
Page
of 50
Search research articles
Search
Showing results (401-410 of 497) with videos related to
Sort By:
Page
of 50
Bratislavske Lekarske Listy
|
November 2, 2010
Protection of ovarian tissue from radiotherapy
C Pafumi, S M Iraci, G Abbate, et al.
JAMA Network Open
|
September 5, 2020
Assessment of Probable Opioid Use Disorder Using Electronic Health Record Documentation
Sarah A Palumbo, Kayleigh M Adamson, Sarathbabu Krishnamurthy, et al.
International Journal of Hematology
|
June 27, 2020
High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity
Giovanni Caocci, Marco Vignetti, Andrea Patriarca, et al.
Cell Proliferation
|
February 16, 2023
Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno-microenvironment in multiple myeloma
Alessandro Barbato, Cesarina Giallongo, Sebastiano Giallongo, et al.
Redox Biology
|
September 1, 2020
Iron regulates myeloma cell/macrophage interaction and drives resistance to bortezomib
Giuseppina Camiolo, Alessandro Barbato, Cesarina Giallongo, et al.
Leukemia & Lymphoma
|
June 23, 2017
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide
Rossana Maffei, Stefania Fiorcari, Silvia Martinelli, et al.
Cancer Medicine
|
September 18, 2015
Early lenalidomide treatment for low and intermediate-1 International Prognostic Scoring System risk myelodysplastic syndromes with del(5q) before transfusion dependence
Esther N Oliva, Michael Lauseker, Maria Antonietta Aloe Spiriti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 2011
Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party
G D'Arena, C G Valentini, G Pietrantuono, et al.
International Journal of Molecular Sciences
|
February 3, 2019
α-Lipoic Acid Reduces Iron-induced Toxicity and Oxidative Stress in a Model of Iron Overload
Giuseppina Camiolo, Daniele Tibullo, Cesarina Giallongo, et al.
Leukemia
|
February 5, 2011
Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement
M A Dimopoulos, A Palumbo, M Attal, et al.
Page
of 50